Literature DB >> 24449200

1p34.3 deletion involving GRIK3: Further clinical implication of GRIK family glutamate receptors in the pathogenesis of developmental delay.

Toshiki Takenouchi1, Noriko Hashida, Chiharu Torii, Rika Kosaki, Takao Takahashi, Kenjiro Kosaki.   

Abstract

A growing body of evidence suggests an association between microdeletion/microduplication and schizophrenia/intellectual disability. Abnormal neurogenesis and neurotransmission have been implicated in the pathogenesis of these neuropsychiatric and neurodevelopmental disorders. The kainate/AMPA-type ionotropic glutamate receptor (GRIK = glutamate receptor, ionotropic, kainate) plays a critical role in synaptic potentiation, which is an essential process for learning and memory. Among the five known GRIK family members, haploinsufficiency of GRIK1, GRIK2, and GRIK4 are known to cause developmental delay, whereas the roles of GRIK3 and GRIK5 remain unknown. Herein, we report on a girl who presented with a severe developmental delay predominantly affecting her language and fine motor skills. She had a 2.6-Mb microdeletion in 1p34.3 involving GRIK3, which encodes a principal subunit of the kainate-type ionotropic glutamate receptor. Given its strong expression pattern in the central nervous system and the biological function of GRIK3 in presynaptic neurotransmission, the haploinsufficiency of GRIK3 is likely to be responsible for the severe developmental delay in the proposita. A review of genetic alterations and the phenotypic effects of all the GRIK family members support this hypothesis. The current observation of a microdeletion involving GRIK3, a kainate-type ionotropic glutamate receptor subunit, and the neurodevelopmental manifestation in the absence of major dysmorphism provides further clinical implication of the possible role of GRIK family glutamate receptors in the pathogenesis of developmental delay.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  GRIK3; developmental delay; glutamate receptor

Mesh:

Substances:

Year:  2013        PMID: 24449200     DOI: 10.1002/ajmg.a.36240

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

Review 1.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Authors:  Hongjie Yuan; Chian-Ming Low; Olivia A Moody; Andrew Jenkins; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

2.  Ultrarare Loss-of-Function Mutations in the Genes Encoding the Ionotropic Glutamate Receptors of Kainate Subtypes Associated with Schizophrenia Disrupt the Interaction with PSD95.

Authors:  Tsung-Ming Hu; Chia-Liang Wu; Shih-Hsin Hsu; Hsin-Yao Tsai; Fu-Yu Cheng; Min-Chih Cheng
Journal:  J Pers Med       Date:  2022-05-12

Review 3.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

4.  MACF1, Involved in the 1p34.2p34.3 Microdeletion Syndrome, is Essential in Cortical Progenitor Polarity and Brain Integrity.

Authors:  Minhan Ka; Jeffrey J Moffat; Woo-Yang Kim
Journal:  Cell Mol Neurobiol       Date:  2021-04-19       Impact factor: 4.231

5.  de novo interstitial deletions at the 11q23.3-q24.2 region.

Authors:  Jiasun Su; Rongyu Chen; Jingsi Luo; Xin Fan; Chunyun Fu; Jin Wang; Sheng He; Xuyun Hu; ShuJie Zhang; Shang Yi; Shaoke Chen; Yiping Shen
Journal:  Mol Cytogenet       Date:  2016-05-05       Impact factor: 2.009

6.  Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood.

Authors:  Alex Hatzimanolis; Pallav Bhatnagar; Anna Moes; Ruihua Wang; Panos Roussos; Panos Bitsios; Costas N Stefanis; Ann E Pulver; Dan E Arking; Nikolaos Smyrnis; Nicholas C Stefanis; Dimitrios Avramopoulos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-05-12       Impact factor: 3.568

7.  A gain-of-function mutation in the GRIK2 gene causes neurodevelopmental deficits.

Authors:  Yomayra F Guzmán; Keri Ramsey; Jacob R Stolz; David W Craig; Mathew J Huentelman; Vinodh Narayanan; Geoffrey T Swanson
Journal:  Neurol Genet       Date:  2017-01-31

8.  Exploring Potential Biomarkers Underlying Pathogenesis of Alzheimer's Disease by Differential Co-expression Analysis.

Authors:  Fereshteh Izadi; Mohammad Hasan Soheilifar
Journal:  Avicenna J Med Biotechnol       Date:  2018 Oct-Dec

9.  Prenatal diagnosis of 1p34.3 interstitial microdeletion by aCGH in a fetus with jaw bone abnormalities.

Authors:  Themistoklis Dagklis; Elena Papageorgiou; Elisavet Siomou; Vassilis Paspaliaris; Christina Zerva; Panagiotis Chatzis; Loretta Thomaidis; Emmanouil Manolakos; Ioannis Papoulidis
Journal:  Mol Cytogenet       Date:  2016-10-06       Impact factor: 2.009

10.  Interstitial microdeletion of the 1p34.3p34.2 region.

Authors:  Joseph E Jacher; Jeffrey W Innis
Journal:  Mol Genet Genomic Med       Date:  2018-05-03       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.